Melanotan I Research: MC1R and Pigment Cell Studies

Last updated: June 2026

A Melanotan I research compound is a synthetic alpha-MSH analog. Alpha-MSH is a 13-amino-acid neuropeptide found in the skin. It binds the MC1R receptor on melanocyte cell surfaces. MC1R stands for melanocortin 1 receptor. Binding at MC1R raises cAMP inside the cell. cAMP activates PKA and drives MITF expression. MITF controls tyrosinase gene output in melanocytes. Tyrosinase then produces pigment in cell culture models. Lab teams study this pathway in B16-F10 melanoma cells. Primary human melanocytes and HEKn cells are also used.

Next Level Pharm is a US-based supplier of research-grade Melanotan I, verified to ≥99.4% purity by HPLC and mass spectrometry on every batch. Each lot ships with a COA and a lot number for full traceability.

Key Takeaways

MC1R is the target receptor: Melanotan I binds MC1R on melanocyte cells. Binding drives cAMP, PKA, and MITF.
Three cell models used: B16-F10, primary melanocytes, and HEKn cells are used. Each allows tyrosinase and MITF measurement.
Key assays confirm pathway activity: Spectrophotometry measures pigment output. Tyrosinase assays and MITF western blots confirm the MC1R pathway.
COA-verified lots: Next Level Pharm ships lyophilized Melanotan I lots with HPLC and mass spec data on every batch. Each lot has a traceable number.
Research use only: All Melanotan I in this catalog is for laboratory research use only. No clinical outcomes are claimed.

How Does Melanotan I Bind the MC1R Receptor?

Melanotan I binds MC1R with high affinity. Binding triggers Gs protein and raises cAMP.

According to Langan et al. (2010), MC1R is a Gs protein-coupled receptor. It sits on the outer surface of melanocyte cells. When a peptide binds MC1R, Gs protein activates. Gs then activates adenylyl cyclase in the cell. Adenylyl cyclase converts ATP to cyclic AMP (cAMP). cAMP then activates protein kinase A (PKA). PKA phosphorylates the transcription factor CREB. CREB then drives MITF gene expression in the nucleus. MITF is the master regulator of melanocyte identity. MITF promotes tyrosinase output, and tyrosinase produces pigment.

How Does MT-I Compare With MT-II and Alpha-MSH?

MT-I is linear and binds MC1R with high selectivity. MT-II is cyclic and less selective.

According to Rouzaud et al. (2006), alpha-MSH is the native MC1R ligand. It is a 13-residue peptide released from POMC. Melanotan I (MT-I) mirrors this sequence with added stability. Melanotan II (MT-II) is a shorter cyclic peptide. MT-II binds MC1R, MC3R, MC4R, and MC5R together. MT-I binds MC1R with much higher selectivity than MT-II. High selectivity means cleaner data in MC1R cell studies. Researchers who need MC1R-only data prefer MT-I. The table below shows key structural differences.

Compound	Structure	MC1R Selectivity	Half-Life
Alpha-MSH	Linear, 13 aa	Moderate	Short
Melanotan I	Linear analog	High	Extended
Melanotan II	Cyclic lactam	Low	Extended

All compounds are for laboratory research only.

Which Cell Models Are Used in Melanotan I Studies?

B16-F10, primary melanocytes, and HEKn cells are used. Each model allows cAMP and pigment measurement.

According to Swope et al. (2012), B16-F10 is a standard melanocyte model. It is a mouse melanoma cell line with high MC1R expression. B16-F10 cells respond to alpha-MSH analogs in assays. Researchers apply MT-I at defined concentrations for 48-72 hours. Primary human melanocytes are the second common model. They carry endogenous MC1R for more relevant data. HEKn cells are human epidermal keratinocytes used for pigment studies. HEKn cells also express MC1R on their surfaces. All three models allow cAMP measurement and MITF western blot. Cell studies only, no human subjects are involved.

How Do Researchers Measure Tyrosinase Activity?

A DOPA oxidation assay measures tyrosinase in cell lysates. Absorbance at 475 nm tracks enzyme output.

The assay uses L-DOPA as its main substrate. Tyrosinase converts L-DOPA to dopaquinone in the reaction. Dopaquinone absorbs light at 475 nm wavelength. A plate reader tracks this absorbance over time. Higher absorbance readings indicate higher tyrosinase activity. Cells are first treated with MT-I for 24-72 hours. After treatment, lysates are collected and centrifuged. The supernatant is then mixed with L-DOPA reagent. Absorbance is recorded every 10 minutes for 60 minutes. Final values are normalized to total protein content per well.

How Is MITF Measured in MC1R Research Studies?

Western blot detects MITF protein in cell lysates. It confirms MC1R pathway activation after MT-I exposure.

Cells are treated with MT-I for 48 hours first. After treatment, total protein is extracted by cell lysis. Proteins are separated on an SDS-PAGE gel. MITF migrates at approximately 55 kDa on the gel. A primary anti-MITF antibody is applied overnight at 4 degrees. An HRP-linked secondary antibody is added the next day. ECL chemiluminescent reagent produces a detectable light signal. Band density is measured with gel imaging software. GAPDH or beta-actin serves as the loading control band. Higher MITF band density confirms MC1R pathway activation.

What Research Tools Are Available for Melanotan I Studies?

MC1R studies need a COA-verified MT-I lot. HTRF cAMP kits and tyrosinase reagents are standard tools.

Research teams need a verified Melanotan I lot to run any study. The lot must match the published reference standard for molecular weight and purity. Next Level Pharm verifies each Melanotan I lot by HPLC and mass spectrometry before shipping. cAMP HTRF kits for MC1R studies are sold by major suppliers. Tyrosinase activity kits use L-DOPA and a 475 nm plate reader. MITF western blot kits need an anti-MITF antibody and HRP secondary. View the Melanotan I product page for lot-specific COA and mass spec data.

Frequently Asked Questions

What is Melanotan I in peptide research?

Melanotan I is a synthetic alpha-MSH analog peptide. It binds the MC1R receptor on melanocyte cell surfaces. Binding at MC1R raises intracellular cAMP levels. cAMP then drives PKA, MITF, and tyrosinase activity. These steps increase pigment output in cell culture models. Lab teams use it to study the pigment pathway. Melanotan I is for laboratory research use only. It is not approved for human use or clinical application.

What is MC1R and where is it found?

MC1R stands for melanocortin 1 receptor. It is a G protein-coupled receptor on melanocyte cells. MC1R sits on the outer membrane of melanocyte surfaces. It is also found on keratinocytes and some immune cells. Binding at MC1R activates Gs protein and raises cAMP. cAMP then drives MITF expression and tyrosinase enzyme activity. Researchers study MC1R to map the pigment signaling cascade. It is a key target in pigment biology research.

How does cAMP control pigment in cell studies?

Binding at MC1R raises cAMP inside the melanocyte cell. cAMP stands for cyclic adenosine monophosphate. cAMP activates PKA (protein kinase A), a key enzyme. PKA phosphorylates the transcription factor CREB. CREB then drives MITF gene expression in the nucleus. MITF promotes tyrosinase gene output and pigment production. Higher cAMP levels lead to more pigment in cell models. Researchers measure cAMP using ELISA or HTRF detection kits.

What is the difference between MT-I and MT-II?

MT-I (Melanotan I) is a linear peptide analog. MT-II (Melanotan II) is a shorter cyclic lactam analog. MT-I binds MC1R with high receptor selectivity. MT-II binds MC1R, MC3R, MC4R, and MC5R together. This broader receptor binding profile reduces selectivity. Researchers who need MC1R-specific data prefer MT-I. Both peptides are for laboratory research use only. Neither is approved for any human use or clinical application.

What assays measure MC1R activity in the lab?

The HTRF cAMP assay detects MC1R receptor binding. ELISA-based cAMP detection kits are also widely used. Radioligand competition assays measure MC1R binding affinity. Tyrosinase colorimetric assays confirm downstream pigment output. MITF western blot shows pathway activation at the protein level. All assays require a COA-verified, high-purity peptide lot. Purity at 99% or above is the preferred standard. High purity reduces background noise and distortion in assay results.

What cell lines are used for Melanotan I research?

B16-F10 is a murine melanoma cell line with high MC1R expression. It is the most common model for alpha-MSH analog studies. Primary human melanocytes carry endogenous MC1R naturally. They provide more biologically relevant data for pigment studies. HEKn cells are human epidermal keratinocytes that express MC1R. All three models allow cAMP and tyrosinase activity measurement. Researchers also run MITF western blots in these cell lines. No human subjects are involved in any of these studies.

What purity is needed for MC1R binding studies?

Most MC1R binding assay protocols require at least 95% purity. Lots at 99% or above are preferred for reliable data. Peptide impurities can compete with MT-I at the MC1R site. This competition distorts cAMP readings and apparent potency values. HPLC confirms purity by measuring peak area on the chromatogram. Mass spectrometry confirms molecular weight and compound identity. Both data points are documented on the lot COA. Always check the COA before running any MC1R receptor assay.

Is Melanotan I approved for human use?

No. Melanotan I in this catalog is not approved for human use. It is supplied for laboratory research purposes only. Researchers must comply with all applicable institutional guidelines. No health claims or clinical outcome claims are made here. All lots ship with a COA and a traceable lot number. The COA includes HPLC purity data and mass spectrometry confirmation. This documentation supports research traceability and assay validation only.

Summary

Melanotan I binds MC1R and raises cAMP in melanocyte cells. cAMP activates PKA, which drives MITF and tyrosinase expression. These steps increase pigment output in cell culture models. B16-F10, primary melanocytes, and HEKn cells are the main models used. No human outcome claims are made in this research overview.

Lab assays for MT-I include cAMP ELISA and tyrosinase activity assays. Western blot confirms MITF protein expression after MC1R activation. A COA-verified lot at 99% purity is required for reliable data. High purity reduces fragment interference and supports publishable results.

What Should You Do Next?

Review the COA for your Melanotan I lot before any cell assay.
Confirm HPLC purity and mass spec data match the reference standard.
Select the right cell model: B16-F10, primary melanocytes, or HEKn.
Consult PubMed MC1R protocols before designing your cAMP or tyrosinase assay.
Browse beauty research peptides for related research tools.
Shop research peptides at https://nextlevelpharm.com/shop/.

About the Author

Next Level Pharm Research Team

Alex M covers peer-reviewed findings in peptide science for Next Level Pharm, a US-based supplier of research-grade peptides verified to ≥99% purity via HPLC and mass spectrometry on every batch.

Disclaimer: The information provided on this page is for educational and research purposes only. Next Level Pharm products are intended for laboratory research use only. They are not intended for human consumption, diagnostic, therapeutic, or medicinal purposes. This content does not constitute medical advice. Always consult a licensed healthcare professional before making any health-related decisions.